glp-1 agonists drug class Table 3 from Glucagon-Like Peptide-1 (GLP-1) Receptor Review GLP-1 Agonists for Weight Loss:
Description
Figure 17: Photograph of Professor Viktor Mutt (1923-1998) standing next to Sephadex column

Stroke in diabetic patients

2023 Aug;402(10401):52944

The major limitation of this review is the limited availability of both animal and human studies

This versatility stems from the complex network of intracellular signaling pathways triggered by GLP-1R activation